Success Metrics

Clinical Success Rate
89.9%

Based on 71 completed trials

Completion Rate
90%(71/79)
Active Trials
2(2%)
Results Posted
27%(19 trials)
Terminated
8(8%)

Phase Distribution

Ph not_applicable
10
10%
Ph phase_3
26
27%
Ph early_phase_1
2
2%
Ph phase_1
21
22%
Ph phase_4
18
19%
Ph phase_2
15
16%

Phase Distribution

23

Early Stage

15

Mid Stage

44

Late Stage

Phase Distribution92 total trials
Early Phase 1First-in-human
2(2.2%)
Phase 1Safety & dosage
21(22.8%)
Phase 2Efficacy & side effects
15(16.3%)
Phase 3Large-scale testing
26(28.3%)
Phase 4Post-market surveillance
18(19.6%)
N/ANon-phased studies
10(10.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.5%

71 of 84 finished

Non-Completion Rate

15.5%

13 ended early

Currently Active

2

trials recruiting

Total Trials

96

all time

Status Distribution
Active(3)
Completed(71)
Terminated(13)
Other(9)

Detailed Status

Completed71
unknown9
Terminated8
Withdrawn5
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
96
Active
2
Success Rate
89.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.2%)
Phase 121 (22.8%)
Phase 215 (16.3%)
Phase 326 (28.3%)
Phase 418 (19.6%)
N/A10 (10.9%)

Trials by Status

unknown99%
withdrawn55%
recruiting22%
not_yet_recruiting11%
terminated88%
completed7174%

Recent Activity

Clinical Trials (96)

Showing 20 of 96 trialsScroll for more
NCT06137287Phase 3

A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants

Completed
NCT05496335Phase 1

A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines

Completed
NCT06585696Phase 3

A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Completed
NCT01325090Phase 3

Early Administration of Botox® in Neuropathic Pain Due to Thoracoscopy or Thoracotomy

Withdrawn
NCT06783114Phase 2

A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults

Recruiting
NCT05216250Phase 2

Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor

Completed
NCT06387394Phase 3

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

Completed
NCT06068855Phase 3

A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants

Completed
NCT05028569Phase 3

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Terminated
NCT06218251Phase 4

A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines

Completed
NCT06399718Phase 3

A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

Completed
NCT06174688Phase 3

A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants

Completed
NCT04609020Phase 4

Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment

Completed
NCT05141006Phase 2

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Completed
NCT06199336Phase 1

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Completed
NCT05218785

Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a

Recruiting
NCT06840158Phase 3

Double-blind Comparative Randomized Multicenter

Completed
NCT06755099Phase 2

Female Sexual Dysfunction Assessment and Managment of Vaginismus

Not Yet Recruiting
NCT05006417Phase 4

Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome

Terminated
NCT05956509Phase 1

Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
96